{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-030014","form_type":"8-K","ticker":"WOOF","cik":"0001826470","company_name":"Petco Health & Wellness Company, Inc.","filed_at":"2022-08-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.269763+00:00","generated_at":"2026-06-23T21:47:46.113494+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Petco Q2 revenue up 3.2% to $1.48B, EPS drops to $0.05 from $0.28 YoY; FY22 guidance updated","bullets":["Net revenue $1.48B (+3.2% YoY); comparable sales +3.8%, marking 15th consecutive quarterly growth.","Net income $13.5M ($0.05 EPS) vs $75.1M ($0.28 EPS) prior year; adjusted EPS $0.19 vs $0.25.","Adjusted EBITDA $142M, down $13.1M YoY; FY22 guidance: revenue $5.975B-$6.05B, Adj EBITDA $580M-$595M.","EPS hit by $55.4M non-cash investment write-down and $10.9M integration costs for Thrive JV buyout."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-030014","json":"https://secwatch.observer/filing/0001564590-22-030014.json","markdown":"https://secwatch.observer/filing/0001564590-22-030014.md","text":"https://secwatch.observer/filing/0001564590-22-030014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826470/000156459022030014/0001564590-22-030014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826470/000156459022030014/woof-8k_20220824.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:47:46.113494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}